Skip to Content

Coronavirus information for Feinberg.

Download the full-sized PDF of Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response
Download the file

Actions

Download Analytics Citations

Export to: EndNote

Collections

This file is in the following collections:

COVID-19 Community

Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response Open Access (recommended)

De Souza A, Tavora FA, Mahalingam D, Munster PN, Safran HP, El-Deiry WS, Carneiro BA. Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response. Frontiers in Immunology. 2020;11:3.

Descriptions

Resource type(s)
Editorial
Keyword
glycogen synthase kinase-3 (GSK3)
glycogen synthase kinase-3 (GSK-3) inhibitor
COVID-19
COVID
9-ING-41
GSK-3b inhibitor
GSK-3 inhibitor
SARS-CoV21
Rights
Attribution 4.0 International

Creator
De Souza, Andre
Tavora, Fabio A.
Mahalingam, Devalingam
Munster, Pamela N.
Safran, Howard P.
El-Deiry, Wafik S.
Carneiro, Benedito A.
Related URL
Publisher
FRONTIERS MEDIA SA
Date Created
2020-10-19
Original Identifier
(PMID) 33193448
DOI
10.3389/fimmu.2020.595289

File Details

File Properties
Mime type: application/pdf
File size: 127.3 kB